Scynexis Inc
Officers & Directors
1. Marco Taglietti, M.D. e President, Chief Executive Officer and Director
Dr. Taglietti has over 30 years of experience in the pharmaceutical industry. Prior to joining Scynexis in 2015, he served as President of Forest Research Institute, a subsidiary of Forest Laboratories Inc. He has also held senior leadership positions at Elan Pharmaceuticals, SangStat Medical Corporation, and SmithKline Beecham Pharmaceuticals.
2. Eric Francois, Ph.D. e Chief Scientific Officer
Dr. Francois has extensive experience in drug discovery and development. Prior to joining Scynexis in 2012, he held various research and leadership positions at Wyeth Research, Pharmacia, and Pfizer.
3. Richard Barton, Ph.D. e Chief Financial Officer
Dr. Barton has over 20 years of experience in the biotechnology industry. Prior to joining Scynexis in 2015, he served as Chief Financial Officer of Clarient Inc., a cancer diagnostics company. He has also held leadership positions at Abraxis Bioscience, Anadys Pharmaceuticals, and Aramed.
4. David Angulo, M.D. e Chief Medical Officer
Dr. Angulo has over 20 years of experience in the pharmaceutical and medical device industries. Prior to joining Scynexis in 2017, he served as Vice President of Clinical Development at GlaxoSmithKline. He has also held senior leadership positions at Endo Pharmaceuticals, Johnson & Johnson, and Medtronic Guy Macdonald e Chairman of the Board
Mr. Macdonald has over 30 years of experience in the pharmaceutical and biotechnology industries. He is also a co-founder and Managing Director of Lighthouse Capital Partners, a venture capital firm.
2. Gary Jacob e Board Member
Dr. Jacob has over 25 years of experience in the pharmaceutical industry, including serving as President and Chief Executive Officer of Synergy Pharmaceuticals Inc. and Senior Vice President of Research and Development for Forest Laboratories Inc.
3. Michael Goldberg, M.D. e Board Member
Dr.Goldberg is a former Partner and Chief Operating Officer of Venrock, a venture capital firm, and has experience in clinical development, regulatory affairs, and medical affairs.
4. Kathleen Bloch e Board Member
Ms. Bloch served as the Senior Vice President of Business Development at Becton Dickinson and Company, a medical technology company, and has extensive experience in corporate strategy and business development.
5. Kenneth Takeshita, M.D. e Board Member
Dr. Takeshita has over 20 years of experience in the pharmaceutical industry, including serving as Chief Medical Officer of Kite Pharma and Executive Vice President of Research and Development at Amgen.
Scynexis Inc currently has 100 employees.
|